AstraZeneca reported $16.2 billion Q3 revenue, up 7%, as oncology grew 17% and Farxiga fell 25% after US generics.
BL Cestrian Capital Research Oct 30 2 clicks
Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.
BL Cestrian Capital Research Oct 30 1 click
Bloom may have reopened imports of scandium-containing components from China to the United States, according to new trade data.
BL Hunterbrook Oct 30 4 clicks
Markel spent $315 million repurchasing shares in Q3 as Thrive agreed to buy ADT for $7.6 billion and Hasbro cited rising adult toy demand.
S TSOH Investment Research Oct 30 1 click
Verisk Analytics’ 40 petabytes of proprietary insurance data and regulatory infrastructure shield its underwriting business from generative…
S First Strike Research Oct 30 7 clicks
Applied Materials posted 51% growth while trading near 23 times forward earnings; memory spending and fab construction support orders, but…
SA Capital Minded Oct 30 1 click Marvell’s reported Lumentum bid would combine DSPs, lasers and optical modules, but $4 billion of cash and $5 billion of debt point to a…
S Vik's Newsletter Oct 30 1 click
SoFi’s stock case hinges on interest rates, tangible book value and private-credit loan sales after its $1.5 billion equity offering.
S WHAT ARE WE DOING? “Contrarians At The Gate” Oct 29 3 clicks
Intel’s Q3 2026 datacenter CPU shortage reflects wafer-start planning failures, not substrate constraints, after demand shifted from client…
S Irrational Analysis Oct 29 2 clicks
Alphabet, Amazon and Intel face market pressure as the big three cloud giants reaffirm AI spending plans.
BL The Technology Letter Oct 29 1 click
Occidental Petroleum’s Q1 2026 execution and operating outperformance were offset by a costly management derivative misstep.
Nasdaq’s QQQ amassed $456 billion through aggressive marketing, turning index licensing into a larger earnings source than trading, data…
S Net Interest May 8 1 click
Domino’s 99%-franchised model converts global retail sales into royalties and supply-chain revenue, but $4.8 billion of debt and mature…
S Bearhold Research May 8 2 clicks
Novo Nordisk’s adjusted Q1 sales fell 4% despite 22% obesity-care growth, as lower US prices outweighed volume gains.
Coupang’s data scandal cut active customers to 23.9 million, but 80% of departed WOW members had returned by April as vouchers and…
BL Speedwell Research May 6
Adobe trades at 11x earnings despite $24.5 billion of revenue, 37% operating margins and 12% profit growth; a former data-science head…
Stripe’s startup-focused product sprawl contrasts with Adyen’s enterprise restraint; despite 20% more payment volume and faster growth,…
Sleep Well Portfolio publishes its 24th pick and updates Grab, Sea, WiseTech and Veeva as software stocks stabilize.
S Sleep Well Investments May 4 1 click
Altria's Q1 2026 revenue rose 3.2% and adjusted EPS 7.3%, while oral tobacco share fell to 29% amid nicotine-pouch competition and a long…
Berkshire Hathaway’s dot-com-era performance frames AI-boom comparisons, Atlassian beats earnings, and Roblox shares fall.
S Ian’s Insider Corner May 3